VIT B2 CTR SRT 200MG 200 MG
VITAMIN B2 : 200 MG · DIN 00539996 · BIOENERGY INC.
Health Canada status: CANCELLED POST MARKET
What is VIT B2 CTR SRT 200MG?
VIT B2 CTR SRT 200MG 200 MG contains VITAMIN B2 : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 00539996, held by BIOENERGY INC., supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Jun-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00539996 |
|---|---|
| Brand name | VIT B2 CTR SRT 200MG |
| Generic / active ingredient | VITAMIN B2 : 200 MG |
| Manufacturer | BIOENERGY INC. |
| Strength | 200 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A11HA04 RIBOFLAVIN (VIT B2) |
| AHFS class | 88:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Jun-1998 |
| Original market date | 1979-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A11HA04 RIBOFLAVIN (VIT B2). 0 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTI-RIBO/RIBO 5-PHOSPH CAPLET | 100 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | DIN 00899542 |
| B-2 CAPS 100MG | 100 MG | CAPSULE | TWIN LABORATORIES INC. | CANCELLED POST MARKET | DIN 01984101 |
| B2 TAB 100MG | 100 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 00450650 |
| RIBOFLAVIN 5 PHOSPHATE CAP 50MG | 50 MG | CAPSULE | THORNE RESEARCH CANADA LTD. | CANCELLED POST MARKET | DIN 00653527 |
| RIBOFLAVIN INJ 50MG/ML | 50 MG | SOLUTION | KRIPPS PHARMACY LTD. | DORMANT | DIN 00463442 |
| RIBOFLAVIN TAB 10MG | 10 MG | TABLET | SWISS HERBAL REMEDIES LTD. | CANCELLED POST MARKET | DIN 00189138 |
| RIBOFLAVIN TAB 5MG | 5 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 00179434 |
| RIBOFLAVIN-S TAB 25MG | 25 MG | TABLET | NUTRI-WEST PRODUCTS LTD. | CANCELLED POST MARKET | DIN 01980769 |
| VITA-FLAVINE CAP 100MG | 100 MG | CAPSULE | LES LABORATOIRES VACHON INC. | CANCELLED POST MARKET | DIN 00757780 |
| VITAMIN B-2 | 100 MG | CAPSULE | SISU INC. | CANCELLED POST MARKET | DIN 02243881 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.